Citations 1
Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.
Shih, Kent C. , Patel, Manish R. , Butowski, Nicholas , Kizilbash, Sani H. , Bacha, Jeffrey , Brown, Dennis , Schwartz, Richard S. , Kanekal, Sarath, Constant, John C.I., Burris, Howard A. , Kizilbash, Sani H , Falchook, Gerald Steven , Jones, Suzanne Fields
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2061-2061
